The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity
Authors:
- Julie SvaløJSJulie Svalø
- Jørgen NordlingJNJørgen Nordling
- Kirsten BoucheloucheKBKirsten Bouchelouche
- Karl-Erik AnderssonKAKarl-Erik Andersson
- Cees KorstanjeCKCees Korstanje
- Pierre BouchelouchePBPierre Bouchelouche
- 1 January 2013
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 699 (1-3) , 101-105
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive BladderAdvances in Urology, 2011
- Antimuscarinic Mechanisms and the Overactive Detrusor: An UpdateEuropean Urology, 2011
- Effects of CL316,243, a β3‐adrenoceptor agonist, and intravesical prostaglandin E2on the primary bladder afferent activity of the ratNeurourology and Urodynamics, 2010
- Pharmacological treatment of overactive bladder: report from the International Consultation on IncontinenceCurrent Opinion in Urology, 2009
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-AnalysisEuropean Urology, 2008
- CLINICAL PROOF OF CONCEPT STUDY (BLOSSOM) SHOWS NOVEL β3 ADRENOCEPTOR AGONIST YM178 IS EFFECTIVE AND WELL TOLERATED IN THE TREATMENT OF SYMPTOMS OF OVERACTIVE BLADDEREuropean Urology Supplements, 2008
- Relaxation of Human Detrusor Muscle by Selective Beta-2 and Beta-3 Agonists and Endogenous CatecholaminesUrology, 2007
- The effects of a new selective β 3 ‐adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladderBJU International, 2006
- Urinary Bladder Contraction and Relaxation: Physiology and PathophysiologyPhysiological Reviews, 2004
- Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder functionThe Lancet, 2001